\
&
Contact us
\
&
Contact us
Background stories of how others approached and experienced their European Horizon funding trajectory.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for detailsPublished on • 1 year ago
These testimonials share at least one programme or target audience.
The Horizon Europe project DemoTrans: Interchange between Democratic Institutions and the Globalisation of the Economy investigates how European societies can sustain and enhance democratic governance in the era of globalisation, economic power concentration, and growing public concern regarding equity, fairness and accountability in the political sphere.
The project responded to call topic HORIZON-CL2-2021-DEMOCRACY-01-02 and is coordinated by KU Leuven.
